Lumos Pharma Inc. Stock News

InflaRx N.V. (NASDAQ:LUMO) has received an average broker rating score of 3.00 (Hold) from the one brokers that cover the company, Zacks Investment Research reports. One analyst has rated the stock wi

ACADIA Pharmaceuticals (NASDAQ:ACAD) initiated with a Buy rating and a $60 (33% upside) price target at Jefferies.eHealth (NASDAQ:EHTH) initiated with an Overweight rating and a $150 (26% upside) pric

The "Global Immune Checkpoint Inhibitors Market Outlook 2022" report has been added to ResearchAndMarkets.com's offering.

Lumos Pharma, Inc. (LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced the promotion of John C. McKew, PhD to the position of Chief Operating Office

The "Global Immune Checkpoint Inhibitors Market Outlook 2022" report has been added to ResearchAndMarkets.com's offering.

Dublin, April 01, 2020 -- The "Global Immune Checkpoint Inhibitors Market Outlook 2022" report has been added to ResearchAndMarkets.com's offering. Given the.

Stocks like MRNA stock have soared on hopes they will benefit from the coronavirus pandemic. But history shows few, if any, actually will.

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Be

NEW YORK (AP) — Changes announced in corporate dividends: INCREASED DIVIDENDS Benchmark Electronics .16 from .15 Cousins Properties .30 from .29 Guaranty Bancshares .19 from .18 Independent Bank Cor